Menu
/REGISTER
Montecito
Pac Premier
Loading...
You are here:  Home  >  'FDA'  -  Page 10
Latest

Amgen drug Kyprolis gets another FDA approval

By   /  Thursday, January 21st, 2016  /  Central Coast Health Watch, East Ventura County, Latest news  /  Comments Off on Amgen drug Kyprolis gets another FDA approval

Amgen scored another victory for its breakthrough multiple myeloma drug on Jan. 21. The Thousand Oaks-based biotech giant hit it big when the Food and Drug Administration approved revolutionary multiple myeloma drug Kyprolis for treatments with Kyprolis in combination with another drug. The FDA also approved Kyprolis to treat patients on its own for those Read More →

Read More →
Latest

Amgen suffers setback as patent office refuses to review competitor’s drug

By   /  Thursday, January 14th, 2016  /  Central Coast Health Watch, East Ventura County, Latest news  /  Comments Off on Amgen suffers setback as patent office refuses to review competitor’s drug

The U.S. Patent and Trademark Office handed Amgen a potential setback Jan. 14 when it declined to review two patent expiration dates on a competitor’s drug. In June, Thousand Oaks-based biotech giant Amgen asked the agency to review two formulation patents for Humira, made by Chicago-based competitor AbbVie, arguing that the patents should not have Read More →

Read More →
Latest

Surgeons clamor for Sientra implants

By   /  Friday, January 8th, 2016  /  Central Coast Health Watch, Latest news, Top Stories, Top Story, Tri-County Public Companies  /  Comments Off on Surgeons clamor for Sientra implants

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Sientra faces disclosure lawsuits

By   /  Friday, December 18th, 2015  /  Central Coast Health Watch, Latest news, Law, left, Top Stories, Tri-County Public Companies  /  Comments Off on Sientra faces disclosure lawsuits

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Novartis biosimilar works as well as Amgen’s Neulasta

By   /  Monday, December 7th, 2015  /  Central Coast Health Watch, Latest news, Tri-County Public Companies  /  Comments Off on Novartis biosimilar works as well as Amgen’s Neulasta

Swiss pharmaceutical Novartis announced Monday that a copycat version of Amgen’s Neulasta works just as well to prevent a condition that can lead to infection in women with breast cancer. Neulasta stimulates white blood cell production in the body, which helps the body fight cancer. Novartis’ new drug is part of a new class of Read More →

Read More →
Latest

Amgen bipolar about biosimilars

By   /  Friday, December 4th, 2015  /  Central Coast Health Watch, Latest news, Top Stories, Tri-County Public Companies  /  Comments Off on Amgen bipolar about biosimilars

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Diabetes drug may be game changer

By   /  Friday, November 27th, 2015  /  Central Coast Health Watch, Latest news, Top Stories  /  Comments Off on Diabetes drug may be game changer

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →